Dr. Aithal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1311 Bristol Pike
Ste 100
Bensalem, PA 19020Phone+1 215-645-1740Fax+1 855-720-6876
Summary
- I am board certified in medical oncology, hematology, and internal medicine with an interest in breast cancer. I believe in an integrated and personalized approach to patient care, as treatment isn't a "one size fits all" option, and I focus on treating the whole person, not just the disease. Additionally, with a goal to assist in the advancement of the field of oncology, I am the principal investigator in several clinical research trials.
Education & Training
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008- Maimonides Medical CenterChief Residency, Internal Medicine, 2004 - 2005
- Maimonides Medical CenterResidency, Internal Medicine, 2001 - 2005
Dr. BR Ambedkar Medical CollegeClass of 1994, MD
Certifications & Licensure
PA State Medical License 2008 - 2024
NY State Medical License 2004 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer Start of enrollment: 2018 Dec 07
Publications & Presentations
PubMed
- 9 citationsPreservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when adde...Volkmar Mueller, Andrew M Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak
European Journal of Cancer. 2021-06-29 - 22 citationsImmunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplificationSally Agersborg, Christopher Mixon, Thanh Nguyen, Sramila Aithal, Sucha Sudarsanam
Breast Cancer Research and Treatment. 2018-03-22 - 7 citationsReduced expression of TGF β1RII in agnogenic myeloid metaplasia is not due to mutation or methylationKirugaval C. Hemavathy, Tsong H. Chang, Haowei Zhang, William Charles, Amit Goldberg
Leukemia Research. 2006-01-01
Press Mentions
CTCA Doctor Talks Breast Cancer Awareness, Prevention and New Treatment OptionsNovember 3rd, 2019- CTCA Hosts Worldwide Spiritual Leader ConferenceFebruary 28th, 2019
Drug Used to Treat Bone Loss Offers Hope for Women at High Risk for Breast CancerJune 27th, 2016
Professional Memberships
- Member
Industry Relationships
- Speaker, PfizerSpeaking engagements on various Breast cancer topics2019 - Present
- Speaker, NovartisSpeaking engagements on Breast cancer topics2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
